BioCentury
ARTICLE | Company News

Cypros, Enquay Inc. deal

December 8, 1997 8:00 AM UTC

CYPR acquired from Enquay two controlled release topical wound care drugs, Sildimac and Medimac, for an undisclosed amount. Sildimac contains silver sulfadiazine, a topical antimicrobial to treat burn...